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OBJECTIVES We sought to evaluate the utility of excluding myocardial infarction (MI) in patients
presenting to the emergency department (ED) with atrial fibrillation (AF) and to identify
predictors of MI in this group.
BACKGROUND Patients with AF are frequently admitted to the hospital, in part, to exclude an associated MI.
There are no prospective data on unselected patients to support this common practice.
METHODS We conducted a prospective cohort study of all patients who presented to a single-center ED
with the primary diagnosis of AF.
RESULTS Of a total of 255 patients, 190 (75%) were admitted to the hospital, and 109 of them
underwent a standard “rule-out MI” protocol. Of these 109 patients, six (5.5%) were
identified as having an acute MI at the time of admission. Chest pain was present in 39% of
patients, with a sensitivity and specificity for the occurrence of MI of 100% and 65%,
respectively. ST segment elevation or depression was present in 43% of patients, with a
sensitivity and specificity of 100% and 51%. The presence of either major ST segment
depression (.2 mm) or elevation on the admission electrocardiogram (ECG) was present in
6%, with a sensitivity of 100% and a specificity of 99%. The resulting positive and negative
predictive values were 86% (95% confidence interval [CI] 42% to 99%) and 100% (95% CI
96% to 100%), respectively. Use of this criterion would have reduced the number of rule-out
MIs in our study group by 94%, with no loss of sensitivity.
CONCLUSIONS Chest pain and ST segment depression are extremely common findings in patients presenting
to the ED with AF and have limited power to predict MI. In contrast, ECG evidence of ST
segment elevation or depression .2 mm appears to be a reliable discriminator of which
patients are at risk for MI. Patients without significant ST segment changes are at very low
risk for MI and may not require performance of the rule-out MI protocol or hospital
admission if clinically stable. (J Am Coll Cardiol 2000;36:1223–7) © 2000 by the American
College of Cardiology
Atrial fibrillation (AF) is the most common arrhythmia
diagnosis in the U.S. population. It is currently present in
nearly 2.2 million Americans, and its prevalence is expected
to increase with the aging population in the coming decades
(1). Atrial fibrillation occurring as a complication of myo-
cardial infarction (MI) is associated with a poor prognosis
(2,3). Although the importance of AF as a primary marker
for MI is uncertain, it is common practice for patients with
AF to be admitted to the hospital for evaluation of a
possible MI. The goal of the current study was to determine
the appropriateness of this practice.
METHODS
Patient group. Between January 1998 and January 1999,
we prospectively identified and followed all patients with
AF who presented to the emergency department (ED) of
the Beth Israel Deaconess Medical Center. Demographic
and clinical data were collected prospectively by a trained
research nurse using standardized case report forms. Addi-
tional information collected included treatments performed
in the ED (antiarrhythmic therapy, cardioversion), patient
disposition (admit, discharge, indication) and clinical course
once admitted.
During the study period, 255 patients presented to the
ED with a primary diagnosis of new onset, recurrent (i.e.,
paroxysmal) or chronic AF (Fig. 1). Sixty-five patients were
discharged directly from the ED, and 190 patients were
admitted to the hospital. Of these 190 patients, 109 (57%)
underwent a standard “rule-out MI” protocol at the discre-
tion of the primary treating physician. These patients
formed the primary analytic cohort for this study.
Classification of symptoms. Symptoms, including chest
pain, dyspnea and palpitations, were recorded as described
by the patient to the ED physician. Because of difficulties in
defining and enforcing standard definitions, we did not
attempt to further specify the quality or severity of these
symptoms.
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Electrocardiographic classification. All 12-lead electro-
cardiograms (ECGs) were independently analyzed by two
cardiologists (M.E.J. and P.Z.). The extent of ST segment
elevation or depression was measured (to the nearest milli-
meter) in the leads with maximal depression or elevation.
ST segment changes were measured at the maximal point of
depression or elevation beginning at 80 ms after the QRS
complex. To maximize the sensitivity of the ECG for the
detection of myocardial ischemia, we did not attempt to
differentiate potentially nonspecific ST segment depressions
or depressions associated with left ventricular hypertrophy
from more “ischemic-appearing” ST segment depressions.
We prospectively defined major ST segment changes as any
ST segment elevation or depression .2 mm. Minor ST
segment changes were defined as ST segment depression
#2 mm. Left ventricular hypertrophy was defined according
to the criteria of Romhilt and Estes (4).
Determination of MI. The standard rule-out MI protocol
included three serial creatine phosphokinase, MB isoen-
zyme (CPK-MB) determinations during a minimal 24-h
admission to a medical floor with full disclosure telemetery.
A patient was considered to have experienced a MI if any
CPK-MB measurement was greater than two times the
upper limit of normal (i.e., .20 IU/ml) (5).
Statistical analysis. Continuous data are described as the
mean value 6 SD, and categoric data are described as
frequencies. Confidence limits were calculated using exact
techniques. The association between the diagnosis of MI
and specific clinical or electrophysiologic characteristics was
evaluated using the t test for continuous variables or the
Fisher exact test for categoric variables. A p value ,0.05 was
considered statistically significant.
RESULTS
The total patient group consisted of the 255 consecutive
patients who presented to the ED of the Beth Israel
Deaconess Medical Center with a primary diagnosis of AF.
The baseline characteristics of the total group, as well as of
the subgroups (those who did and did not undergo the
rule-out MI protocol) admitted to the hospital, are shown in
Table 1. Compared with the patients who were either not
admitted or admitted with no evaluation for MI, those
patients in the rule-out MI group were older and more likely
to be male and to carry a diagnosis of hypertension. The
rule-out MI group was more likely to present with symp-
toms of chest pain or shortness of breath, but less likely to
complain of palpitations. In the rule-out MI group, both
new-onset and recurrent paroxysmal AF were common; no
patients with chronic AF underwent evaluation for MI.
Approximately one-half of the rule-out MI group had some
ST segment depression or elevation on the admission ECG,
but only 7% had major ST segment abnormalities.
Among the rule-out MI group, the primary physician
listed a single reason for hospital admission (i.e., MI
evaluation) in 30%, but two or more reasons in 70% of cases.
The most common other indications for hospital admission
in this group included rate control (48%), cardioversion
(31%) and initiation of anticoagulation (39%).
Table 2 compares the clinical and ECG features of those
with and without MI in the subgroup that underwent the
rule-out MI protocol (n 5 109). The only clinical factors
associated with MI were the presence of chest pain on
presentation and new-onset AF. Other factors, including
age, history of coronary artery disease and symptoms such as
palpitations or shortness of breath at presentation, were not
useful predictors of the occurrence of MI in our analytic
cohort. Electrocardiographic factors predictive of MI in-
cluded the presence of ST segment elevation or .2 mm of
ST segment depression.
The performance characteristics of various clinical and
ECG criteria for distinguishing patients with and without
MI are summarized in Table 3. The presence of major ST
segment abnormalities on the presenting ECG (defined as
.2 mm of ST segment depression or any ST segment
elevation) was the best predictor of a subsequent MI, with
nearly perfect sensitivity and specificity and a positive
predictive value of 86% (95% confidence interval [CI] 42%
to 99%) and a negative predictive value of 100% (95% CI
96% to 100%). The other potential criteria (new-onset AF,
chest pain on presentation, any ST segment abnormalities)
were also highly sensitive predictors of a subsequent MI, but
had only modest discriminatory power owing to their
limited specificities and resulting low positive predictive
values (95% CI 11% to 14%).
The remaining 146 patients who did not undergo the
rule-out MI protocol were followed clinically for subsequent
complications, including possible myocardial ischemia or
infarction. There were no instances of readmission for
Abbreviations and Acronyms
AF 5 atrial fibrillation
CI 5 confidence interval
CPK-MB 5 creatine phosphokinase, MB isoenzyme
ECG 5 electrocardiogram or electrocardiographic
ED 5 emergency department
MI 5 myocardial infarction
Figure 1. Diagram of consecutive patients who presented to the ED with
AF over a one-year period.
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myocardial ischemia or infarction, cardiac catheterization or
revascularization procedures performed in the month after
their initial presentation. If, on the basis of their benign
clinical courses, these patients were assumed not to have
suffered a clinically significant MI at the time of presenta-
tion, the discriminatory power of major ST segment
changes on the admitting ECG was unchanged, with a
positive predictive value of 86% (95% CI 42% to 99%) and
a negative predictive value of 100% (95% CI 98% to 100%).
DISCUSSION
Incidence of MI. This study represents a comprehensive
evaluation of all patients with AF who presented to a large
urban hospital over a one-year period. In the subgroup of
patients who underwent the rule-out MI protocol, we found
that the incidence of MI at the time of admission was
relatively low (6 [5.5%] of 109 patients). If those patients
who were discharged or did not undergo systematic moni-
toring of cardiac isoenzymes, but had a benign subsequent
clinical course, were also considered to have “ruled-out” for
MI, the incidence of clinically significant MI in our AF
group was only 2.3% (6 of 255 patients).
The relatively low incidence of MI in this patient group
is not surprising. Previous studies have reported the inci-
dence of MI in patients with new-onset AF to be 11% (6).
In our population-based series, the incidence of docu-
mented MI was even lower, in part because only 69% of
patients who underwent evaluation for MI had either chest
pain or some evidence of myocardial ischemia on their
admission ECG. This reflects the common practice in our
institution (and many others) of admitting patients with AF
to monitor for possible MI, even in the absence of any
supporting signs or symptoms. Our study does not support
this practice, however. Among the 31% of patients without
chest pain or ST segment deviation on their admission
ECG, there were no confirmed MIs.
Predictors of MI. Despite the low incidence of MI in our
group, we identified several objective clinical and ECG
features whose absence could be helpful in reliably identify-
ing a subgroup of patients at extremely low risk of MI.
These features include new-onset AF, the presence of chest
pain and the presence of ST segment depression or elevation
on the admission ECG. Although each of these factors was
sensitive for the occurrence of MI, their value as potential
discriminating factors for deciding which patients to admit
and rule out MI and which to consider for less intensive
management was limited by their low specificities (50% to
65%), and thus low positive predictive values (11% to 14%).
In particular, the value of chest pain as a predictor of the
occurrence of MI in this patient group was poor, with a
positive predictive value of only 14% (95% CI 5% to 29%).
This finding is consistent with previous studies of AF in
which chest pain was a relatively common but nonspecific
finding (7,8).
The most sensitive and specific predictor of MI was the
presence of major ST segment deviation—defined as
.2 mm of ST segment depression or any ST segment
elevation—on the presenting ECG. In our patient group,
this single factor was an excellent discriminator of patients
with and without MI, with a positive predictive value of
Table 1. Characteristics of the Total Study Group and Subgroups That Did and Did Not








(n 5 146) p Value*
Age (yrs) 69 6 15 74 6 14 66 6 15 0.001
Male gender 51% 59% 42% 0.04
Hypertension 60% 68% 54% 0.04
Diabetes mellitus 17% 20% 17% NS
Known CAD 26% 31% 23% NS
History of CHF 12% 14% 12% NS
Symptoms on presentation
Chest pain 25% 39% 14% , 0.001
Shortness of breath 42% 54% 32% 0.001
Palpitations 57% 43% 67% , 0.001
Type of AF 0.001
New onset 39% 51% 30%
Recurrent 56% 49% 61%
Chronic 5% 0% 8%
ECG changes
Any† 40% 46% 35% 0.09
Major ST segment‡ 4% 7% 1% 0.04
Minor ST segment§ 36% 39% 34% NS
LVH 29% 37% 23% 0.02
*p Values reflect comparison between the rule-out MI group (analytic cohort) and the remainder of the patient group. †Any ST
segment depression or elevation. ‡ST segment elevation or depression .2 mm. §ST depression #2 mm. Data are presented as
the mean value 6 SD or percentage of patients.
AF 5 atrial fibrillation; CAD 5 coronary artery disease; CHF 5 congestive heart failure; ECG 5 electrocardiographic;
LVH 5 left ventricular hypertrophy; NS 5 not significant.
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86% (95% CI 42% to 99%) and a negative predictive value
of 100% (95% CI 96% to 100%). This finding suggests that
the vast majority of patients admitted to the hospital for
evaluation of a possible MI might be managed equally well
in a less intensive setting—either on an unmonitored
medical unit or in the outpatient setting. In fact, use of this
criterion would have reduced the number of MI evaluations
in our group by 94%, with no loss of sensitivity. Even the
adoption of less stringent ECG criteria, such as the presence
of any degree of ST segment deviation, would have identi-
fied all of the patients with an acute MI in our group, while
allowing for 46% to be managed more conservatively.
Although evaluation for a possible MI was cited fre-
quently by the primary physician as an indication for
hospital admission in our AF group, it is uncertain whether
better risk stratification would substantially alter this prac-
tice and the high rate of hospital admission for these
patients. In fact, most patients in our rule-out MI group had
more than one indication for hospital admission, and
evaluation for ongoing myocardial ischemia or infarction
was cited as the sole indication for admission in only 21%.
Nonetheless, many of the other indications for admission,
including rate control, cardioversion and initiation of anti-
coagulation, can be safely performed on an outpatient basis
with appropriate patient education, close follow-up and
ancillary support (9). In contrast, ongoing myocardial isch-
emia or infarction is generally an “absolute” indication for
hospital admission and close observation (10). Thus, we
believe that more precise identification of patients with AF
who are at risk for MI could substantially reduce the rate of
hospital admission without affecting overall outcomes or
quality of care.
Study limitations. Our study has several important limi-
tations. The major limitation of our study is that the
diagnostic thresholds we identified for prediction of MI
among patients with AF were selected on a post-hoc basis.
Accordingly, our findings should be viewed as hypothesis-
generating and will require validation in an independent
data set before their widespread implementation in clinical
practice. Second, given the limited number of MIs in our
patient group, the confidence limits for our estimates of
sensitivity (and positive predictive value) are wide. None-
theless, the major role of our diagnostic criteria is in
identifying patients at low risk for MI who do not neces-
sarily require hospital admission if otherwise stable. The
value of these criteria is thus related mainly to their negative
predictive values, for which the confidence limits are sub-
stantially more narrow. Finally, the fact that our group was
drawn from a single, urban, academic medical center may
also limit the generalizability of our findings to other
settings and patient groups.
Conclusions. Despite the common practice of admitting
patients with AF to the hospital to “rule out MI,” the
incidence of MI in such patients without other evidence of
myocardial ischemia is low. The presence of major ST
segment abnormalities on the presenting ECG was both a
sensitive and specific predictor of MI in our patients. Use of
this criterion (or other related factors) must be prospectively
validated, but may avoid unnecessary testing and hospital
admissions and result in important cost savings without loss
of quality of care.
Table 2. Association of Clinical and Electrocardiographic





(n 5 103) p Value
Clinical features
Age (yrs) 74 6 15 74 6 14 NS
History of CHF 0% 13% NS
History of CAD 67% 29% NS
New-onset AF 100% 48% 0.01
Chest pain 100% 35% 0.01
Shortness of breath 67% 53% NS
ECG features
Mean ventricular response 124 6 33 118 6 27 NS
LVH 50% 37% NS
Q waves 33% 12% NS
RBBB 17% 4% NS
LBBB 0% 6% NS
ST segment elevation 50% 0% , 0.001
Any ST segment depression 50% 43% NS
.2 mm 50% 1% , 0.001
1 to 2 mm 0% 7% NS
#1 mm 0% 34% NS
Data are presented as the mean value 6 SD or percentage of patients.
CAD 5 coronary artery disease; CHF 5 congestive heart failure; LBBB 5 left
bundle branch block; MI 5 myocardial infarction; RBBB 5 right bundle branch
block; other abbreviations as in Table 1.








New-onset AF 1.00 (0.54–1.00) 0.51 (0.41–0.61) 0.11 (0.04–0.22) 1.00 (0.93–1.00)
Chest pain 1.00 (0.54–1.00) 0.65 (0.55–0.74) 0.14 (0.05–0.29) 1.00 (0.95–1.00)
ST segment elevation 0.50 (0.12–0.88) 1.00 (0.97–1.00) 1.00 (0.29–1.00) 0.97 (0.92–0.99)
Major ST segment change* 1.00 (0.54–1.00) 0.99 (0.95–0.99) 0.86 (0.42–0.99) 1.00 (0.96–1.00)
Any ST segment change 1.00 (0.54–1.00) 0.51 (0.41–0.22) 0.11 (0.04–0.22) 1.00 (0.93–1.00)
*Defined as .2 mm of ST segment depression or any ST segment elevation. Values in parentheses are 95% confidence intervals.
AF 5 atrial fibrillation.
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